Mirae Asset Global ETFs Holdings’s Standard BioTools LAB Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$289K	Buy	314,120 +5,337	+2%	+$6.46K	﹤0.01%	2172
2025 Q4	$395K	Buy	308,783 +168,175	+120%	+$226K	﹤0.01%	2008
2025 Q3	$183K	Sell	140,608 -23,308	-14%	-$30.5K	﹤0.01%	2367
2025 Q2	$197K	Sell	163,916 -12,355	-7%	-$13.7K	﹤0.01%	2294
2025 Q1	$190K	Buy	176,271 +7,494	+4%	+$10.5K	﹤0.01%	2348
2024 Q4	$295K	Buy	168,777 +7,304	+5%	+$13.6K	﹤0.01%	2182
2024 Q3	$312K	Buy	+161,473	New	+$316K	﹤0.01%	2147

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LAB Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Standard BioTools (LAB) stake by 1.7% in Q1 2026, buying an estimated $6.46K and bringing the position to 314,120 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.

Mirae Asset Global ETFs Holdings first reported a position in LAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $395K in Q4 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

Mirae Asset Global ETFs Holdings held 314,120 shares of Standard BioTools worth $289K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 5,337 Standard BioTools shares in Q1 2026, an estimated $6.46K.
Standard BioTools made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2172 holding.
Mirae Asset Global ETFs Holdings first reported a position in Standard BioTools in Q3 2024 and has held it in 7 quarters since.
Mirae Asset Global ETFs Holdings's Standard BioTools position peaked at $395K in Q4 2025.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.